Longevity and Anti-Aging Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Calcium AKG Supplement,Nicotinamide Mononucleotide Supplement,Others), By Application (Adult Male (Under 60 Years Old),Adult Female (Under 60 Years Old),Elderly (Above 60 Years Old)), Regional Insights and Forecast to 2034

Detailed TOC of Global Longevity and Anti-Aging Drugs Market Research Report 2025

1 Longevity and Anti-Aging Drugs Market Overview
1.1 Product Definition
1.2 Longevity and Anti-Aging Drugs by Type
1.2.1 Global Longevity and Anti-Aging Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Calcium AKG Supplement
1.2.3 Nicotinamide Mononucleotide Supplement
1.2.4 Others
1.3 Longevity and Anti-Aging Drugs by Application
1.3.1 Global Longevity and Anti-Aging Drugs Market Value by Application (2024 VS 2031)
1.3.2 Adult Male (Under 60 Years Old)
1.3.3 Adult Female (Under 60 Years Old)
1.3.4 Elderly (Above 60 Years Old)
1.4 Global Longevity and Anti-Aging Drugs Market Size Estimates and Forecasts
1.4.1 Global Longevity and Anti-Aging Drugs Revenue 2020-2031
1.4.2 Global Longevity and Anti-Aging Drugs Sales 2020-2031
1.4.3 Global Longevity and Anti-Aging Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Longevity and Anti-Aging Drugs Market Competition by Manufacturers
2.1 Global Longevity and Anti-Aging Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Longevity and Anti-Aging Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Longevity and Anti-Aging Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Longevity and Anti-Aging Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Longevity and Anti-Aging Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Longevity and Anti-Aging Drugs, Product Type & Application
2.7 Global Key Manufacturers of Longevity and Anti-Aging Drugs, Date of Enter into This Industry
2.8 Global Longevity and Anti-Aging Drugs Market Competitive Situation and Trends
2.8.1 Global Longevity and Anti-Aging Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Longevity and Anti-Aging Drugs Players Market Share by Revenue
2.8.3 Global Longevity and Anti-Aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Longevity and Anti-Aging Drugs Market Scenario by Region
3.1 Global Longevity and Anti-Aging Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Longevity and Anti-Aging Drugs Sales by Region: 2020-2031
3.2.1 Global Longevity and Anti-Aging Drugs Sales by Region: 2020-2025
3.2.2 Global Longevity and Anti-Aging Drugs Sales by Region: 2026-2031
3.3 Global Longevity and Anti-Aging Drugs Revenue by Region: 2020-2031
3.3.1 Global Longevity and Anti-Aging Drugs Revenue by Region: 2020-2025
3.3.2 Global Longevity and Anti-Aging Drugs Revenue by Region: 2026-2031
3.4 North America Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.4.1 North America Longevity and Anti-Aging Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Longevity and Anti-Aging Drugs Sales by Country (2020-2031)
3.4.3 North America Longevity and Anti-Aging Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.5.1 Europe Longevity and Anti-Aging Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Longevity and Anti-Aging Drugs Sales by Country (2020-2031)
3.5.3 Europe Longevity and Anti-Aging Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Longevity and Anti-Aging Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Longevity and Anti-Aging Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Longevity and Anti-Aging Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Longevity and Anti-Aging Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.7.1 Latin America Longevity and Anti-Aging Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Longevity and Anti-Aging Drugs Sales by Country (2020-2031)
3.7.3 Latin America Longevity and Anti-Aging Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Longevity and Anti-Aging Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Longevity and Anti-Aging Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Longevity and Anti-Aging Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Longevity and Anti-Aging Drugs Sales by Type (2020-2031)
4.1.1 Global Longevity and Anti-Aging Drugs Sales by Type (2020-2025)
4.1.2 Global Longevity and Anti-Aging Drugs Sales by Type (2026-2031)
4.1.3 Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2020-2031)
4.2 Global Longevity and Anti-Aging Drugs Revenue by Type (2020-2031)
4.2.1 Global Longevity and Anti-Aging Drugs Revenue by Type (2020-2025)
4.2.2 Global Longevity and Anti-Aging Drugs Revenue by Type (2026-2031)
4.2.3 Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Longevity and Anti-Aging Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Longevity and Anti-Aging Drugs Sales by Application (2020-2031)
5.1.1 Global Longevity and Anti-Aging Drugs Sales by Application (2020-2025)
5.1.2 Global Longevity and Anti-Aging Drugs Sales by Application (2026-2031)
5.1.3 Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2020-2031)
5.2 Global Longevity and Anti-Aging Drugs Revenue by Application (2020-2031)
5.2.1 Global Longevity and Anti-Aging Drugs Revenue by Application (2020-2025)
5.2.2 Global Longevity and Anti-Aging Drugs Revenue by Application (2026-2031)
5.2.3 Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Longevity and Anti-Aging Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Vitality Pro
6.1.1 Vitality Pro Company Information
6.1.2 Vitality Pro Description and Business Overview
6.1.3 Vitality Pro Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Vitality Pro Longevity and Anti-Aging Drugs Product Portfolio
6.1.5 Vitality Pro Recent Developments/Updates
6.2 MoleQlar
6.2.1 MoleQlar Company Information
6.2.2 MoleQlar Description and Business Overview
6.2.3 MoleQlar Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 MoleQlar Longevity and Anti-Aging Drugs Product Portfolio
6.2.5 MoleQlar Recent Developments/Updates
6.3 Hansen Supplements
6.3.1 Hansen Supplements Company Information
6.3.2 Hansen Supplements Description and Business Overview
6.3.3 Hansen Supplements Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hansen Supplements Longevity and Anti-Aging Drugs Product Portfolio
6.3.5 Hansen Supplements Recent Developments/Updates
6.4 Supplement Place
6.4.1 Supplement Place Company Information
6.4.2 Supplement Place Description and Business Overview
6.4.3 Supplement Place Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Supplement Place Longevity and Anti-Aging Drugs Product Portfolio
6.4.5 Supplement Place Recent Developments/Updates
6.5 Maxx Herb
6.5.1 Maxx Herb Company Information
6.5.2 Maxx Herb Description and Business Overview
6.5.3 Maxx Herb Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Maxx Herb Longevity and Anti-Aging Drugs Product Portfolio
6.5.5 Maxx Herb Recent Developments/Updates
6.6 Youth & Earth
6.6.1 Youth & Earth Company Information
6.6.2 Youth & Earth Description and Business Overview
6.6.3 Youth & Earth Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Youth & Earth Longevity and Anti-Aging Drugs Product Portfolio
6.6.5 Youth & Earth Recent Developments/Updates
6.7 Rejuvant LifeTabs
6.7.1 Rejuvant LifeTabs Company Information
6.7.2 Rejuvant LifeTabs Description and Business Overview
6.7.3 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product Portfolio
6.7.5 Rejuvant LifeTabs Recent Developments/Updates
6.8 Renue By Science
6.8.1 Renue By Science Company Information
6.8.2 Renue By Science Description and Business Overview
6.8.3 Renue By Science Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Renue By Science Longevity and Anti-Aging Drugs Product Portfolio
6.8.5 Renue By Science Recent Developments/Updates
6.9 Double Wood Supplements
6.9.1 Double Wood Supplements Company Information
6.9.2 Double Wood Supplements Description and Business Overview
6.9.3 Double Wood Supplements Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Double Wood Supplements Longevity and Anti-Aging Drugs Product Portfolio
6.9.5 Double Wood Supplements Recent Developments/Updates
6.10 Quicksilver Scientific
6.10.1 Quicksilver Scientific Company Information
6.10.2 Quicksilver Scientific Description and Business Overview
6.10.3 Quicksilver Scientific Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Quicksilver Scientific Longevity and Anti-Aging Drugs Product Portfolio
6.10.5 Quicksilver Scientific Recent Developments/Updates
6.11 California Gold Nutrition
6.11.1 California Gold Nutrition Company Information
6.11.2 California Gold Nutrition Description and Business Overview
6.11.3 California Gold Nutrition Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 California Gold Nutrition Longevity and Anti-Aging Drugs Product Portfolio
6.11.5 California Gold Nutrition Recent Developments/Updates
6.12 ProHealth Longevity
6.12.1 ProHealth Longevity Company Information
6.12.2 ProHealth Longevity Description and Business Overview
6.12.3 ProHealth Longevity Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ProHealth Longevity Longevity and Anti-Aging Drugs Product Portfolio
6.12.5 ProHealth Longevity Recent Developments/Updates
6.13 Peak Performance
6.13.1 Peak Performance Company Information
6.13.2 Peak Performance Description and Business Overview
6.13.3 Peak Performance Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Peak Performance Longevity and Anti-Aging Drugs Product Portfolio
6.13.5 Peak Performance Recent Developments/Updates
6.14 Do Not Age
6.14.1 Do Not Age Company Information
6.14.2 Do Not Age Description and Business Overview
6.14.3 Do Not Age Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Do Not Age Longevity and Anti-Aging Drugs Product Portfolio
6.14.5 Do Not Age Recent Developments/Updates
6.15 Nutriop
6.15.1 Nutriop Company Information
6.15.2 Nutriop Description and Business Overview
6.15.3 Nutriop Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Nutriop Longevity and Anti-Aging Drugs Product Portfolio
6.15.5 Nutriop Recent Developments/Updates
6.16 AFEGA Anti-Aging-Shop
6.16.1 AFEGA Anti-Aging-Shop Company Information
6.16.2 AFEGA Anti-Aging-Shop Description and Business Overview
6.16.3 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product Portfolio
6.16.5 AFEGA Anti-Aging-Shop Recent Developments/Updates
6.17 Xi\'an Angel Biotechnology Co., Ltd.
6.17.1 Xi\'an Angel Biotechnology Co., Ltd. Company Information
6.17.2 Xi\'an Angel Biotechnology Co., Ltd. Description and Business Overview
6.17.3 Xi\'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Xi\'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product Portfolio
6.17.5 Xi\'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
6.18 Longevity Box
6.18.1 Longevity Box Company Information
6.18.2 Longevity Box Description and Business Overview
6.18.3 Longevity Box Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Longevity Box Longevity and Anti-Aging Drugs Product Portfolio
6.18.5 Longevity Box Recent Developments/Updates
6.19 Age Science
6.19.1 Age Science Company Information
6.19.2 Age Science Description and Business Overview
6.19.3 Age Science Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Age Science Longevity and Anti-Aging Drugs Product Portfolio
6.19.5 Age Science Recent Developments/Updates
6.20 Nutravita
6.20.1 Nutravita Company Information
6.20.2 Nutravita Description and Business Overview
6.20.3 Nutravita Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Nutravita Longevity and Anti-Aging Drugs Product Portfolio
6.20.5 Nutravita Recent Developments/Updates
6.21 Aeternum
6.21.1 Aeternum Company Information
6.21.2 Aeternum Description and Business Overview
6.21.3 Aeternum Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Aeternum Longevity and Anti-Aging Drugs Product Portfolio
6.21.5 Aeternum Recent Developments/Updates
6.22 Toniiq
6.22.1 Toniiq Company Information
6.22.2 Toniiq Description and Business Overview
6.22.3 Toniiq Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Toniiq Longevity and Anti-Aging Drugs Product Portfolio
6.22.5 Toniiq Recent Developments/Updates
6.23 ProNutrition
6.23.1 ProNutrition Company Information
6.23.2 ProNutrition Description and Business Overview
6.23.3 ProNutrition Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.23.4 ProNutrition Longevity and Anti-Aging Drugs Product Portfolio
6.23.5 ProNutrition Recent Developments/Updates
6.24 Genex Formulas
6.24.1 Genex Formulas Company Information
6.24.2 Genex Formulas Description and Business Overview
6.24.3 Genex Formulas Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Genex Formulas Longevity and Anti-Aging Drugs Product Portfolio
6.24.5 Genex Formulas Recent Developments/Updates
6.25 Physicians Longevity
6.25.1 Physicians Longevity Company Information
6.25.2 Physicians Longevity Description and Business Overview
6.25.3 Physicians Longevity Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Physicians Longevity Longevity and Anti-Aging Drugs Product Portfolio
6.25.5 Physicians Longevity Recent Developments/Updates
6.26 AlphaFit
6.26.1 AlphaFit Company Information
6.26.2 AlphaFit Description and Business Overview
6.26.3 AlphaFit Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.26.4 AlphaFit Longevity and Anti-Aging Drugs Product Portfolio
6.26.5 AlphaFit Recent Developments/Updates
6.27 Lovita Foods
6.27.1 Lovita Foods Company Information
6.27.2 Lovita Foods Description and Business Overview
6.27.3 Lovita Foods Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Lovita Foods Longevity and Anti-Aging Drugs Product Portfolio
6.27.5 Lovita Foods Recent Developments/Updates
6.28 Jarrow Formulas
6.28.1 Jarrow Formulas Company Information
6.28.2 Jarrow Formulas Description and Business Overview
6.28.3 Jarrow Formulas Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.28.4 Jarrow Formulas Longevity and Anti-Aging Drugs Product Portfolio
6.28.5 Jarrow Formulas Recent Developments/Updates
6.29 Body Union
6.29.1 Body Union Company Information
6.29.2 Body Union Description and Business Overview
6.29.3 Body Union Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2020-2025)
6.29.4 Body Union Longevity and Anti-Aging Drugs Product Portfolio
6.29.5 Body Union Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Longevity and Anti-Aging Drugs Industry Chain Analysis
7.2 Longevity and Anti-Aging Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Longevity and Anti-Aging Drugs Production Mode & Process Analysis
7.4 Longevity and Anti-Aging Drugs Sales and Marketing
7.4.1 Longevity and Anti-Aging Drugs Sales Channels
7.4.2 Longevity and Anti-Aging Drugs Distributors
7.5 Longevity and Anti-Aging Drugs Customer Analysis
8 Longevity and Anti-Aging Drugs Market Dynamics
8.1 Longevity and Anti-Aging Drugs Industry Trends
8.2 Longevity and Anti-Aging Drugs Market Drivers
8.3 Longevity and Anti-Aging Drugs Market Challenges
8.4 Longevity and Anti-Aging Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer